E-cigarette constituents propylene glycol and vegetable glycerin decrease glucose uptake and its metabolism in airway epithelial cells in vitro.


Journal

American journal of physiology. Lung cellular and molecular physiology
ISSN: 1522-1504
Titre abrégé: Am J Physiol Lung Cell Mol Physiol
Pays: United States
ID NLM: 100901229

Informations de publication

Date de publication:
01 12 2020
Historique:
pubmed: 1 10 2020
medline: 8 1 2021
entrez: 30 9 2020
Statut: ppublish

Résumé

Electronic nicotine delivery systems, or e-cigarettes, utilize a liquid solution that normally contains propylene glycol (PG) and vegetable glycerin (VG) to generate vapor and act as a carrier for nicotine and flavorings. Evidence indicated these "carriers" reduced growth and survival of epithelial cells including those of the airway. We hypothesized that 3% PG or PG mixed with VG (3% PG/VG, 55:45) inhibited glucose uptake in human airway epithelial cells as a first step to reducing airway cell survival. Exposure of H441 or human bronchiolar epithelial cells (HBECs) to PG and PG/VG (30-60 min) inhibited glucose uptake and mitochondrial ATP synthesis. PG/VG inhibited glycolysis. PG/VG and mannitol reduced cell volume and height of air-liquid interface cultures. Mannitol, but not PG/VG, increased phosphorylation of p38 MAPK. PG/VG reduced transepithelial electrical resistance, which was associated with increased transepithelial solute permeability. PG/VG decreased fluorescence recovery after photobleaching of green fluorescent protein-linked glucose transporters GLUT1 and GLUT10, indicating that glucose transport function was compromised. Puffing PG/VG vapor onto the apical surface of primary HBECs for 10 min to mimic the effect of e-cigarette smoking also reduced glucose transport. In conclusion, short-term exposure to PG/VG, key components of e-cigarettes, decreased glucose transport and metabolism in airway cells. We propose that this was a result of PG/VG reduced cell volume and membrane fluidity, with further consequences on epithelial barrier function. Taking these results together, we suggest these factors contribute to reduced defensive properties of the epithelium. We propose that repeated/chronic exposure to these agents are likely to contribute to airway damage in e-cigarette users.

Identifiants

pubmed: 32996783
doi: 10.1152/ajplung.00123.2020
pmc: PMC7792687
doi:

Substances chimiques

Propylene Glycol 6DC9Q167V3
Glucose IY9XDZ35W2
Glycerol PDC6A3C0OX

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

L957-L967

Subventions

Organisme : Medical Research Council
ID : MR/K012770/1
Pays : United Kingdom
Organisme : MRF
ID : MRF_MRF-091-0001-RG-GARNE
Pays : United Kingdom
Organisme : NHLBI NIH HHS
ID : P50 HL120100
Pays : United States
Organisme : RCUK | MRC | Medical Research Foundation
ID : MRF-091-0001-RG-GARNE
Pays : International

Références

Am J Kidney Dis. 1997 Jul;30(1):134-9
pubmed: 9214414
Mech Dev. 2015 Nov;138 Pt 3:375-98
pubmed: 26025760
Biochim Biophys Acta. 1991 Oct 14;1069(1):5-13
pubmed: 1932049
Cell Tissue Res. 2007 Nov;330(2):257-69
pubmed: 17768643
Biochem Med Metab Biol. 1988 Feb;39(1):90-7
pubmed: 3355719
Br J Pharmacol. 2012 Sep;167(2):368-82
pubmed: 22509822
Am J Physiol Lung Cell Mol Physiol. 2017 Feb 1;312(2):L258-L267
pubmed: 27979861
PLoS One. 2011 Jan 20;6(1):e16166
pubmed: 21311590
Am J Physiol Lung Cell Mol Physiol. 2013 Jun 1;304(11):L746-56
pubmed: 23542952
Arch Biochem Biophys. 2000 Aug 15;380(2):347-52
pubmed: 10933890
J Clin Invest. 2019 Oct 1;129(10):4290-4304
pubmed: 31483291
Sci Rep. 2017 Aug 7;7(1):7459
pubmed: 28785072
Chest. 2018 Feb;153(2):507-514
pubmed: 28610911
Am J Physiol Lung Cell Mol Physiol. 2020 Feb 1;318(2):L226-L241
pubmed: 31693394
Oxid Med Cell Longev. 2019 Mar 27;2019:2715810
pubmed: 31049129
Biomol Concepts. 2012 Aug;3(4):345-364
pubmed: 22977648
Am J Physiol Cell Physiol. 2001 Oct;281(4):C1365-72
pubmed: 11546675
J Pharm Sci. 2020 Apr;109(4):1483-1492
pubmed: 31884013
Am J Physiol Lung Cell Mol Physiol. 2017 Jul 1;313(1):L52-L66
pubmed: 28428175
BMC Med. 2014 Dec 09;12:226
pubmed: 25488431
Eur Respir J. 2012 Nov;40(5):1269-76
pubmed: 22878875
J Cell Mol Med. 2019 Jan;23(1):317-327
pubmed: 30450773
Pflugers Arch. 2009 Mar;457(5):1061-70
pubmed: 18781323
FASEB J. 2012 Feb;26(2):533-45
pubmed: 21990373
PLoS One. 2013 Oct 04;8(10):e76283
pubmed: 24124542
Am J Physiol Regul Integr Comp Physiol. 2018 Jun 1;314(6):R834-R847
pubmed: 29384700
PLoS Biol. 2018 Mar 27;16(3):e2003904
pubmed: 29584716
Biochim Biophys Acta. 1990 Sep 21;1028(1):43-8
pubmed: 1698456
Thorax. 2018 Sep;73(9):847-856
pubmed: 29748250
PLoS One. 2014 Sep 22;9(9):e108342
pubmed: 25244293
Pflugers Arch. 2008 Aug;456(5):991-1003
pubmed: 18239936
Am J Respir Crit Care Med. 2018 Jul 1;198(1):67-76
pubmed: 29481290
J Biol Chem. 2003 Oct 3;278(40):38484-94
pubmed: 12881532
Respir Res. 2005 Dec 09;6:144
pubmed: 16336673
Biochim Biophys Acta. 2016 Sep;1860(9):2037-52
pubmed: 27261090
Am J Physiol Lung Cell Mol Physiol. 2017 May 1;312(5):L688-L702
pubmed: 28213469
Occup Environ Med. 2001 Oct;58(10):649-55
pubmed: 11555686
Arch Intern Med. 1991 Nov;151(11):2297-8
pubmed: 1953236
Eur Respir J. 2018 Feb 7;51(2):
pubmed: 29437942
Toxicol Sci. 1998 Dec;46(2):410-7
pubmed: 10048145
Am J Respir Crit Care Med. 2019 Nov 1;200(9):1134-1145
pubmed: 31170808
Nicotine Tob Res. 2020 Apr 21;22(5):791-797
pubmed: 31403695
Biochim Biophys Acta. 1999 Jan 8;1415(2):323-30
pubmed: 9889390
Fundam Appl Toxicol. 1994 Jul;23(1):38-43
pubmed: 7958561
Drug Alcohol Depend. 2019 Jan 1;194:326-329
pubmed: 30471584
J Androl. 2000 Sep-Oct;21(5):625-35
pubmed: 10975408
Biochem Med Metab Biol. 1991 Oct;46(2):145-51
pubmed: 1782006
Am J Physiol Lung Cell Mol Physiol. 2015 Jul 15;309(2):L109-18
pubmed: 26001773
Biochem Med Metab Biol. 1989 Oct;42(2):87-94
pubmed: 2789852
PLoS One. 2015 Feb 06;10(2):e0116732
pubmed: 25658421

Auteurs

M Woodall (M)

Institute for Infection and Immunity, St George's, University of London, Tooting, London, United Kingdom.

J Jacob (J)

Institute for Infection and Immunity, St George's, University of London, Tooting, London, United Kingdom.

K K Kalsi (KK)

Institute for Infection and Immunity, St George's, University of London, Tooting, London, United Kingdom.

V Schroeder (V)

Immunology and Respiratory Diseases Research, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany.

E Davis (E)

Marsico Lung Institute and Department of Cell Biology and Physiology, University of North Carolina, Chapel Hill, North Carolina.

B Kenyon (B)

Marsico Lung Institute and Department of Cell Biology and Physiology, University of North Carolina, Chapel Hill, North Carolina.

I Khan (I)

Institute for Infection and Immunity, St George's, University of London, Tooting, London, United Kingdom.

J P Garnett (JP)

Immunology and Respiratory Diseases Research, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany.

R Tarran (R)

Marsico Lung Institute and Department of Cell Biology and Physiology, University of North Carolina, Chapel Hill, North Carolina.

D L Baines (DL)

Institute for Infection and Immunity, St George's, University of London, Tooting, London, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH